Visudyne.com
Sign up for important updates and sample materials on Visudyne.
Click here.
  Novartis Pharma US

 
THE WORLD IS BEAUTIFUL > TO LOOK AT

Understanding AMD

Central to understanding:

Basic facts about age-related macular degeneration

Age-related macular degeneration (AMD) is the leading cause of severe vision loss among the elderly in the western world. Yet only about 1 in 5 Americans knows about this potentially blinding disease.

AMD is a disease of the retina. There are 2 types of the disease, commonly known as "dry" and "wet." AMD can affect everyday activities such as recognizing faces, reading, and driving a car. In its more severe form, AMD can cause permanent loss of a person's central vision, leaving only his or her side vision intact.
Learn more

AMD: Common—but not inevitable
About 25 to 30 million people worldwide are affected by age-related macular degeneration (AMD), and the number is expected to triple over the next 25 years. In the U.S., more than 13 million people are estimated to have AMD, making the condition more common in people over 40 than glaucoma (2 million), though less common than cataracts (20 million).

Common as AMD is, it isn't an inevitable part of growing older. There are steps people can take now to help prevent AMD, and other steps they can take to help avoid its progression and limit its severity.
Learn more

Early detection is key:
Visit your eyecare specialist regularly

Early detection of age-related macular degeneration (AMD) through eye exams is the key to preserving sight. Early detection also means more treatment options, as well as early access to low vision rehabilitation and support services.

So, if you're overdue for a visit to your eyecare specialist, be sure to schedule an appointment soon. And if Visudyne therapy is recommended for you or a loved one, be sure to join the mySight™ information-and-support program. It's FREE to all members and their loved ones.
Learn more

Home  |  Understanding Age-Related Macular Degeneration
AMD Treatment Options  |  About Visudyne
Friends and Family  |  Living with AMD
Visudyne mySight™ Program  |  Resource Center
Important Safety Information  |  Prescribing Information
Rich Media Center  |  Healthcare Professionals

Contact Us  |  Site Guide  |  Site Map
Novartis Pharma US Use of website is governed by the Terms of Use and Privacy Statement.
Copyright ©2008
Novartis Pharmaceuticals Corporation. All rights reserved.

Novartis proudly supports the Together Rx Access program.
Together Rx Access